ReviewHeliyon2024
Optimal features selection in the high dimensional data based on robust technique: Application to different health database.
Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- A Robust Masked Painter Framework for Gene Selection in Binary Classification of High-Dimensional Functional Genomic Data.Entropy (Basel, Switzerland) · 2026Article
- Toward Explainable Precision Nephrology: Machine Learning-Based Chronic Kidney Disease Prediction.Biomedicines · 2026Article
- Machine-Learning-Based Color Sensing Using Wearable SENSIPATCH Spectrometer Module: An Experimental Study.Sensors (Basel, Switzerland) · 2026Article
- Step-Wise Dual Dynamic DPSGD: Enhancing Performance on Imbalanced Medical Datasets with Differential Privacy.Entropy (Basel, Switzerland) · 2026Article
- An Intelligent Hybrid Ensemble Model for Early Detection of Breast Cancer in Multidisciplinary Healthcare Systems.Diagnostics (Basel, Switzerland) · 2026Article
- An intelligent ensemble machine learning model for early detection of chronic kidney disease in aging populations.Scientific reports · 2026Article
- MLP-CKD: a clinically informed deep learning framework for admission laboratory-based screening and risk stratification of uremia-associated advanced renal dysfunction.Frontiers in public health · 2026Article
- Peripheral Blood HIST1H2AE is a Candidate Epigenetic Biomarker for Coronary Artery Disease: A Multi-Dataset Discovery and Comparative Validation Study.International journal of general medicine · 2026Article
- Exploring the multidimensional factors associated with the incidence of bacillary dysentery in China based on a panel data model.Frontiers in public health · 2026Article
- The impact of deep learning and omics data in transforming precision therapy for brain cancer.Frontiers in bioinformatics · 2026Review
- Dynamic spatiotemporal graph attention networks for cross-regional multi-disease forecasting and intervention optimization.Frontiers in public health · 2026Article
- Clinical Application of Machine Learning Models for Early-Stage Chronic Kidney Disease Detection.Diagnostics (Basel, Switzerland) · 2025Article
- The association between the ZJU index and chronic kidney disease: Evidence from the NHANES and GEO databases.Digital healthArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bio-informatics and gene expression analysis face major hurdles when dealing with high-dimensional data, where the number of variables or genes much outweighs the number of samples. These difficulties are exacerbated, particularly in microarray data processing, by redundant genes that do not significantly contribute to the response variable. To address this issue, gene selection emerges as a feasible method for identifying the most important genes, hence reducing the generalization error of classification algorithms. This paper introduces a new hybrid approach for gene selection by combining the Signal-to-Noise Ratio (SNR) score with the robust Mood median test. The Mood median test is beneficial for reducing the impact of outliers in non-normal or skewed data since it may successfully identify genes with significant changes across groups. The SNR score measures the significance of a gene's classification by comparing the gap between class means and within-class variability. By integrating both of these approaches, the suggested approach aims to find genes that are significant for classification tasks. The major objective of this study is to evaluate the effectiveness of this combination approach in choosing the optimal genes. A significant P-value is consistently identified for each gene using the Mood median test and the SNR score. By dividing the SNR value of each gene by its significant P-value, the Md score is calculated. Genes with a high signal-to-noise ratio (SNR) have been considered favorable due to their minimal noise influence and significant classification importance. To verify the effectiveness of the selected genes, the study utilizes two dependable classification techniques: Random Forest and K-Nearest Neighbors (KNN). These algorithms were chosen due to their track record of successfully completing categorization-related tasks. The performance of the selected genes is evaluated using two metrics: error reduction and classification accuracy. These metrics offer an in-depth assessment of how well the selected genes improve classification accuracy and consistency. According to the findings, the hybrid approach put out here outperforms conventional gene selection methods in high-dimensional datasets and has lower classification error rates. There are considerable improvements in classification accuracy and error reduction when specific genes are exposed to the Random Forest and KNN classifiers. The outcomes demonstrate how this hybrid technique might be a helpful tool to improve gene selection processes in bioinformatics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.